Canadian research-driven cannabis extraction Company
MediPharm Labs Inc. (
TSX-V: LABS,
OTCQB:MLCPF,Forum) had a nice bump in its shares Monday on the news that it has appointed Braden Fenske as Chief Strategy Officer. The former
Johnson & JohnsonGroup Product Director will be responsible for advancing the Company’s strategic corporate initiatives in collaboration with the Company’s executives and operational teams across the Company.
For more information on this, click
here.
MediPharm was also covered by
CFN Media Grouplast week, looking further into its plans for global expansion. This includes its Australian operations and first sale of cannabis oil to an Australian company.
FULL DISCLOSURE: MediPharm Labs Inc. is a client of Stockhouse Publishing.